NEWS
Our Latest News
ARCHIMED finalizes the acquisition of IBA Lifesciences GmbH by Cube Biotech
ARCHIMED finalizes the acquisition of IBA Lifesciences GmbH by Cube Biotech
The acquisition represents a transformational transaction for Cube, bringing critical size, complementing Cube’s protein purification portfolio, reinforcing its market position and boosting its profitability.
Partnering with existing owners and management, ARCHIMED acquires majority interest in NAMSA, the world leader in medical device testing
September
1,
2020
ARCHIMED raises €1 billion for its MED Platform I Fund
August
28,
2020
ARCHIMED acquires ActiGraph, the fast-growing leader in remote monitoring of mobility and sleep for drug trials
May
18,
2020
368